Together, these findings suggest that SRC, EGFR, ERK1/2, and Akt, which are key regulators of cell proliferation and survival in breast cancer cells, act as downstream effectors of the WDR7-7-GPR30 pathway, especially in ER− cells due to the absence of an ER-mediated pathway. The gene discussed is MAPK3; the disease is breast carcinoma.